se of Procalcitonin in Diagnosing and Monitoring Diabetic Foot Osteomyelitis and Cellulitis at The Townsville Hospital–A Pilot Study

James Cook University0 个研究点目标入组 50 人开始时间: 2017年8月8日最近更新: 2021年1月18日

适应症

试验速览

暂无简介。

•Patients meeting the following inclusion criteria will be eligible to enter the study:
•1.Subjects with diabetic foot ulcer
•2. Aged 18 years or over
•3.Exclusion of other etiologies of foot ulcer.

•Patients meeting any of the following criteria will not be included in the study:
•1.Clinical infection at the studied ulcer site (bacterial and fungal)
•2.Planned surgical intervention for the diabetic foot ulcer
•3.Clinically significant lower-extremity ischemia (as defined by an ankle/brachial index of <0.65)
•4.Significant medical conditions that would impair wound healing will also be excluded from the study. These conditions include hepatic, respiratory or cardiac failures, aplastic anemia, scleroderma and malignancy, treatment with immunosuppressive agents or steroids, myocardial infarcts, stroke, major surgery within 6 months of the study, or usage of tobacco
•5.Ulcer of a non-diabetic pathophysiology (e.g., rheumatoid, radiation-related, and vasculitis-related ulcers, calciphylaxis or dystrophic calcinosis cutis)
•6.Active malignancy other than basal cell carcinoma as well as subjects with cancerous or pre-cancerous lesions in the ulcer area
•7.Pregnancy
•8.Inability to comply with study protocol

发起方